Peritoneal Mesothelioma Specialist Takes Expertise to South Florida

Dr. Shanel Bhagwandin saw the steady flow of patients who traveled from Southeast Florida to New York’s renowned Mount Sinai Hospital for the specialized treatment of peritoneal mesothelioma cancer. He knew there was a better way, and he just made it happen. Bhagwandin made the 1,200-mile move himself — from Mount Sinai to the Jupiter Medical Center — to start the latest surgical oncology program that specializes in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). “This procedure can make a tremendous difference,” Bhagwandin told Asbestos.com. “And it makes a world of difference for a patient and his family when they don’t have to go across the country to get the treatment they need.” Procedure Key for Mesothelioma Treatment Bhagwandin, who grew up in South Florida, has spent considerable time at the Jupiter Medical Center raising awareness of his program with patients and medical professionals. The cytoreduction and HIPEC combination has become a key strategy in treating a variety of abdominal malignancies. Its effectiveness has allowed peritoneal mesothelioma patients to survive considerably longer than ever before. Many today are living five to 10 years and beyond, which was unheard of a decade ago. According to one study involving more than 100 patients at the Columbia University Medical Center, the median overall survival rate was 6.65 years. And 30 percent of the patients had a survival estimate of more than 10 years. An earli...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news